Hypothesis for risk of death or serious sequela from asthmatic use of magnesium throat lozenges due to 8- to 310-fold rhinovirus release increase by concentrated magnesium

Medical Hypotheses

Volumn 74, Issue 1, 2010, Pages 206-207

  Eby, George ^a  

^a George Eby Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATIN; MAGNESIUM; MAGNESIUM CHLORIDE; MAGNESIUM ION; ZINC DERIVATIVE;

ALLERGY; ASTHMA; COMMON COLD; DIET SUPPLEMENTATION; DISEASE EXACERBATION; DRUG EFFICACY; DRUG USE; HUMAN; HYPOTHESIS; IN VITRO STUDY; LETTER; LOZENGE; LUNG INJURY; MORTALITY; PRIORITY JOURNAL; RHINOVIRUS; RHINOVIRUS INFECTION; VIROGENESIS;

ASTHMA; HUMANS; LUNG; MAGNESIUM; MAGNESIUM CHLORIDE; MODELS, BIOLOGICAL; MODELS, THEORETICAL; MOUTH; PHARYNX; RHINOVIRUS; RISK; TABLETS;

RHINOVIRUS;

EID: 70549103396     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.07.035     Document Type: Letter

References (7)

1. Eby G.A. Rescue treatment and prevention of asthma using magnesium throat lozenges: hypothesis for a mouth-lung biologically closed electric circuit. Med Hypotheses 67 (2006) 1136-1141
2. Gern J.E. Rhinovirus and the initiation of asthma. Curr Opin Allergy Clin Immunol. 9 (2009) 73-78
3. Fiala M., and Kenny G.E. Effect of magnesium on replication of rhinovirus HGP. J Virol 1 (1967) 489-493
4. Fiala M. Plaque formation by 55 rhinovirus serotypes. Appl Microbiol 16 (1968) 1445-1450
5. Geist F.C., Bateman J.A., and Hayden F.G. In vitro activity of zinc salts against human rhinoviruses. Antimicrob Agents Chemother 31 (1987) 622-624
6. Eby G.A. Zinc lozenges: cold cure or candy? Solution chemistry determinations. Biosci Rep 24 1 (2004) 23-39
7. Eby GA. A review of ionizable zinc (iZn) dose-response criteria from zinc lozenges for common cold clinical trials (1984-2009), Submitted for publication.